The increases were relatively small, but researchers say they highlight the need for physicians to closely monitor patients on GLP-1s and suggest interventions when necessary and for patients to make lifestyle changes that can boost bone and joint health
(PubMed) Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS
The trial enrolled 120 adults and children as young as four, randomized 2:1 to once-daily subcutaneous setmelanotide or placebo, and ran for a full year, making it the largest and longest placebo-controlled study ever conducted in this patient population
This is generally a benefit, but it carries a risk of hyperkalemia, which is a condition where potassium levels in the blood become too high
This surge reflects a paradigm shift in how we approach diabetes and obesity management
Hard work and perseverance really paid off in the end